Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Infant Ment Health J ; 44(1): 76-91, 2023 01.
Artigo em Inglês | MEDLINE | ID: mdl-36565696

RESUMO

"Attachment and Biobehavioural Catch-Up" (ABC) is a 10 session home visiting program, grounded in attachment theory. It aims to improve child emotion regulation, attachment and behavioral outcomes through changing caregivers' attachment related behaviors. There is increasing evidence with respect to the effectiveness of ABC in producing positive child outcomes, but the intervention's direct effect on parent outcomes remains unclear. This review examined the association of ABC with attachment related parent outcomes. The PubMed, EMBASE, PyschINFO and SCOPUS databases were searched for relevant studies in August 2021, and again in April 2022. The eligibility criteria for included studies were (1) infants aged 0-27 months at time of the ABC intervention, (2) "at risk" parents, (3) controlled trials published in peer-reviewed journals and (4) utilized a measure of attachment related parent outcomes. Eleven eligible studies were included. The findings showed ABC had a significant small to medium effect on a variety of attachment related parent outcomes among parents presenting with multiple psychosocial risk factors. "Sensitivity" was measured most frequently, with small to medium main effect sizes recorded at follow-up, compared to controls. Implications for the clinical effectiveness of the ABC program in community settings are discussed. Future research should clarify who ABC is most effective for and how it compares to similar interventions.


"El Alcance de Afectividad y Biocounducta" (ABC) es un programa de visita a casa en 10 sesiones, fundamentado en la teoría de la afectividad. Su meta es mejorar en el niño los resultados de la regulación de la emoción, de afectividad y de comportamiento por medio de cambiar el comportamiento relacionado con la afectividad de quien presta el cuidado. La evidencia con respecto a la eficacia de ABC para producir resultados positivos en el niño va en aumento, pero el efecto directo de la intervención sobre el resultado en el progenitor aún no está claro. Esta revisión examinó la asociación entre ABC y los resultados en el progenitor relacionados con la afectividad. Se investigaron los bancos de datos PubMed, EMBASE, PyschINFO y SCOPUS en agosto de 2021 en busca de estudios relevantes, lo cual se hizo otra vez en abril de 2022. Los criterios para elegir los estudios que se incluirían fueron (1) infantes de edad entre 0 y 27 meses al momento de la intervención ABC, (2) progenitores "bajo riesgo," (3) ensayos controlados publicados en revistas de aceptación profesional rigurosa y (4) la utilización de una medida de afectividad relacionada con los resultados en el progenitor. Se incluyeron once estudios que reunían los criterios. Lo que encontramos mostró que ABC tenía un efecto entre significativamente pequeño y medio en cuanto a una variedad de afectividad relacionada con los resultados en el progenitor entre progenitores que presentaban múltiples factores de riesgo sicosociales. La "sensibilidad" fue medida con mayor frecuencia, con anotación de la dimensión de los efectos de pequeños a medianos al momento del seguimiento, en comparación con el grupo de control. Se discuten las implicaciones para la eficacia clínica de ABC en la comunidad. La investigación futura debe aclarar para quién es ABC más eficaz y cómo se compara con intervenciones similares.


"L'attachement et le rattrapage bio-comportemental" (Attachment and Biobehavioural Catch-Up, soit ABC) est un programme de visite à domicile de 10 sessions, basé sur la théorie de l'attachement. Il a pour but d'améliorer la régulation de l'émotion de l'enfant, l'attachement et les résultats de comportement en changeant les comportements liés à l'attachement de la personne prenant soin du bébé. On a de plus en plus de données pour ce qui concerne l'efficacité de l'ABC à donner des résultats positifs pour l'enfant, mais l'effet direct de l'intervention sur le résultat parental n'est pas très clair. Ce compte-rendu a examiné le lien de l'ABC avec les résultats d'attachement liés au parent. Les bases de données PubMed, EMBASE, PyschINFO et SCOPUS ont fait l'objet d'une recherche pour des études pertinentes à ce sujet en août 2021 et à nouveau en avril 2022. Les critères d'éligibilité pour les études inclues ont été (1) bébés âgés de 0-27 mois au moment de l'intervention ABC, (2) parents "à risque", (3) essais contrôlés publiés dans des publications à comité de lecture et (4) ayant utilisé une mesure d'attachement liée aux résultats du parent. Onze études éligibles ont été inclues. Les résultats ont montré que l'ABC avait un effet relativement petit à moyen sur plusieurs résultats du parent liés à l'attachement chez les parents présentant plusieurs risques psychosociaux. La "sensibilité" a été mesurée le plus fréquemment, avec des tailles d'effet de petit à moyen enregistrées au suivi, comparés aux contrôles. Les implications pour l'efficacité clinique de l'ABC dans un contexte de communauté sont discutées. Les recherches futures devraient clarifier pour qui l'ABC est le plus efficace et comment on peut le comparer à des interventions similaires.


Assuntos
Regulação Emocional , Poder Familiar , Lactente , Criança , Humanos , Poder Familiar/psicologia , Apego ao Objeto , Pais/psicologia , Cuidadores
2.
JMIR Res Protoc ; 10(12): e22125, 2021 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-34914613

RESUMO

BACKGROUND: Multimorbidity is defined as the presence of two or more chronic diseases and associated comorbidities. There is a need to improve best practices around the provision of well-coordinated, person-centered care for persons with multimorbidities. Present health systems across the European Union (EU) focus on supporting a single-disease framework of care; the primary challenge is to create a patient-centric, integrated care ecosystem to understand and manage multimorbidity. ProACT is a large-scale project funded by the European Commission under the Horizon 2020 programme, that involved the design, development, and evaluation of a digital health platform to improve and advance home-based integrated care, and supported self-management, for older adults (aged ≥65 years) living with multimorbidity. OBJECTIVE: This paper describes the trial implementation protocol of a proof-of-concept digital health platform (ProACT) in 2 EU member states (Ireland and Belgium) to support older persons with multimorbidities self-managing at home, supported by their care network (CN). METHODS: Research was conducted across 2 EU member states, Ireland and Belgium. A 12-month action research trial design, divided into 3 evaluation cycles and lasting 3 months each, with a reflective redesign and development phase of 1 month after cycles 1 and 2 was conducted. Participants were 120 (60/120, 50% in Ireland and 60/120, 50% in Belgium) older persons with multimorbidities diagnosed with two or more of the following chronic conditions: diabetes, chronic obstructive pulmonary disease, chronic heart failure, and cardiovascular diseases. With permission from persons with multimorbidities, members of their CN were invited to participate in the study. Persons with multimorbidities were provided with ProACT technologies (tablet, devices, or sensors) to support them in self-managing their conditions. CN members also received access to an app to remotely support their persons with multimorbidity. Qualitative and quantitative feedback and evaluation data from persons with multimorbidity and CN participants were collected across four time points: baseline (T1), at the end of each 3-month action research cycle (T2 and T3), and in a final posttrial interview (T4). Thematic analysis was used to analyze the qualitative interview data. Quantitative data were analyzed via platform use statistics (to assess engagement) and standardized questionnaires (using descriptive and inferential statistics). This study is approved by the ethics committees of Ireland and Belgium. RESULTS: The trial implementation phase for this 44-month (2016-2019) funded study was April 2018 to June 2019. The trial outcomes are at various stages of publication since 2021. CONCLUSIONS: ProACT aims to co-design and develop a digital intervention with persons with multimorbidities and their CN, incorporating clinical guidelines with the state of the art in human-computer interaction, behavioral science, health psychology, and data analytic methods to deliver a digital health platform to advance self-management of multimorbidity at home, as part of a proactive, integrated model of supported person-centered care. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR1-10.2196/22125.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA